UW Medicine
Welcome,         Profile    Billing    Logout  
 2 Trials 
31 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ehde, Dawn M
NCT03782246: MBCT and CBT for Chronic Pain in Multiple Sclerosis

Active, not recruiting
N/A
273
US
MBCT, CBT
University of Washington, National Multiple Sclerosis Society
Multiple Sclerosis
08/22
08/22
E-TIPS, NCT04248725: Telehealth Pain Self-Management for Employed Adults

Completed
N/A
202
US
E-TIPS
University of Washington, National Institute on Disability, Independent Living, and Rehabilitation Research
Chronic Pain, Brain Injuries, Traumatic, Multiple Sclerosis, Spinal Cord Injuries, Amputation
09/23
03/24
NCT06270641: Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Recruiting
N/A
106
US
ExerciseRx intervention, Exercise Intervention, Best Practice, App-Based Intervention, Interview, Questionnaire Administration
University of Washington
Multiple Sclerosis (MS), Fatigue, Physical Inactivity
04/25
09/26
Alschuler, Kevin N
Cubii, NCT05826431: for Exercise in People With MS

Completed
N/A
21
US
Cubii elliptical
University of Washington
Multiple Sclerosis, Fatigue, Activity, Motor, Quality of Life
08/23
12/23
NCT05252195: Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS)

Active, not recruiting
N/A
300
US
University of Michigan, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Wayne State University, University of Washington
Multiple Sclerosis
03/27
03/27
Patrick, Alicia
RESPITE, NCT05625360: REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss

Recruiting
3
160
US
eHealth Mindful Movement and Breathing, Life Impacts Reflection, PROMIS Questionnaires
Wake Forest University Health Sciences, National Cancer Institute (NCI)
Postoperative Pain, Acute, Postoperative Depression, Anxiety, Sleep Disturbance, Malignant Female Reproductive System Neoplasm
08/26
08/26
ASPIRE, NCT06866964: A Single-arm, Phase II Clinical Trial of ASPIRin to PrEvent Venous Thromboembolism in Patients with Advanced Germ Cell Tumors Receiving Chemotherapy

Not yet recruiting
2
35
US
Low-dose ASA, aspirin
Wake Forest University Health Sciences, Atrium Health Wake Forest Baptist
Germ Cell Tumor, Testicular Cancer
08/29
01/31
IMPPACT, NCT04727827: Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation

Completed
N/A
110
US
Pharmacogenomic-guided supportive care
Wake Forest University Health Sciences
Hematopoietic Cell Transplantation, Oncology
06/23
06/23
ACCESS, NCT04602611: Impact Of Nurse Navigation Program on Outcomes in Patients With GI Cancers

Completed
N/A
228
US
Oncology Nurse Navigation
Wake Forest University Health Sciences
Gastrointestinal Cancer
08/23
08/23
NCT04659135: ASCO Survey on COVID-19 in Oncology (ASCO) Registry

Active, not recruiting
N/A
7000
US
American Society of Clinical Oncology
Neoplasms, Coronavirus
08/24
01/25
NCT06291324: WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment

Recruiting
N/A
46
US
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Pancreatic Cancer, Breast Cancer
12/25
12/25
CISTO, NCT03933826: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer

Active, not recruiting
N/A
572
US
University of Washington, Patient-Centered Outcomes Research Institute
Bladder Cancer, Cancer of the Bladder, Recurrent, Non-muscle Invasive Bladder Cancer
01/25
06/29
NCT05415358: Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

Recruiting
N/A
23
US
Blood and tissue samples
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute, Atrium Health Wake Forest Baptist
Lung Cancer, Nonsmall Cell
09/35
09/35
NCT06795087: Discharge Medication Use Post-Operatively in GU Cancer Patients

Recruiting
N/A
684
US
Opioid Medication Disposal Education
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Genitourinary Cancer
07/26
07/26
VAP, NCT06634381: Patient Descriptors of Cancer-Related Fatigue: a Mixed Methods Pilot Study of Cancer Survivors

Recruiting
N/A
80
US
CRF Visual Aid
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Cancer, Fatigue
06/25
06/25
ONC-LUN-2401, NCT06567704: Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

Recruiting
N/A
40
US
Interviews
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Non-small Cell Lung Cancer
04/25
08/25
NCT06489041: Evaluating Microarray Pharmacogenetic Testing in Cancer Patients

Recruiting
N/A
120
US
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Cancer, Gastrointestinal Cancer
05/25
05/25
NCT05934851: A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia

Recruiting
N/A
112
US
Frozen-Section Directed Excision, FSDE, Wide Local Excision
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Vulvar Neoplasm, Dysplasia Vulvar
08/26
03/27
realMIND, NCT04981795: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Recruiting
N/A
100
US
Tafasitamab
Incyte Corporation, Iqvia Pty Ltd
Diffuse Large B-cell Lymphoma
10/25
08/26
PROSPECT, NCT04930445: Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

Terminated
N/A
262
US
Oxbryta® (voxelotor) 500mg Tablets, Voxelotor, Oxbryta®
Pfizer, Pfizer
Sickle Cell Disease
10/24
10/24
Chihara, Dai
NCT06563505: A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

Recruiting
2
36
US
Mosunetuzumab, RO7030816, Zanubrutinib
M.D. Anderson Cancer Center
Lymphoma
12/26
12/28
NCT06670105: A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma

Not yet recruiting
2
30
US
Glofitamab
M.D. Anderson Cancer Center, Genentech, Inc.
B-cell Lymphoma
01/30
01/32
NCT06108232: Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

Recruiting
2
36
US
Obinutuzumab, GA101, Gazyva, RO5072759, CC-99282
M.D. Anderson Cancer Center, Bristol-Myers Squibb
Follicular Lymphoma, Tumor
12/25
12/27
NCT05886036: Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Recruiting
2
70
Canada, US
Biopsy Procedure, Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Mosunetuzumab, Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody BTCT4465A, BTCT 4465A, BTCT-4465A, BTCT4465A, CD20/CD3 BiMAb BTCT4465A, Lunsumio, Mosunetuzumab-axgb, RG 7828, RG-7828, RG7828, RO7030816, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, PT, Rituximab, ABP 798, ABP-798, ABP798, BI 695500, BI-695500, BI695500, Blitzima, C2B8 Monoclonal Antibody, Chimeric Anti-CD20 Antibody, CT P10, CT-P10, CTP10, GP 2013, GP-2013, GP2013, IDEC 102, IDEC-102, IDEC-C2B8, IDEC-C2B8 Monoclonal Antibody, IDEC102, Ikgdar, Mabtas, MabThera, Monoclonal Antibody IDEC-C2B8, PF 05280586, PF-05280586, PF05280586, Riabni, Ritemvia, Rituxan, Rituximab ABBS, Rituximab ARRX, Rituximab Biosimilar ABP 798, Rituximab Biosimilar BI 695500, Rituximab Biosimilar CT-P10, Rituximab Biosimilar GB241, Rituximab Biosimilar GP2013, Rituximab Biosimilar IBI301, Rituximab Biosimilar JHL1101, Rituximab Biosimilar PF-05280586, Rituximab Biosimilar RTXM83, Rituximab Biosimilar SAIT101, Rituximab Biosimilar SIBP-02, rituximab biosimilar TQB2303, Rituximab PVVR, Rituximab-abbs, Rituximab-arrx, Rituximab-blit, Rituximab-pvvr, Rituximab-rite, Rituximab-rixa, Rituximab-rixi, Rixathon, Riximyo, RTXM 83, RTXM-83, RTXM83, Ruxience, Truxima, Rituximab and Hyaluronidase Human, Rituxan Hycela, Rituximab Plus Hyaluronidase, Rituximab/Hyaluronidase, Rituximab/Hyaluronidase Human
National Cancer Institute (NCI)
Nodular Lymphocyte Predominant B-Cell Lymphoma, Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma, Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
10/26
10/26
PROSPECT, NCT04947319: Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma ( Study)

Recruiting
2
112
US
Tirabrutinib, ONO-4059
Ono Pharmaceutical Co. Ltd
Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma
03/27
03/27
NCT06045247: Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Recruiting
2
40
US
Prednisone, Rituximab, Cyclophosphamide, Vincristine, Epcoritamab
M.D. Anderson Cancer Center
Large B-cell Lymphoma
07/28
07/30
SET-101, NCT05121103: A Study of the Safety, Tolerability and Effectiveness of EZM0414 Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma

Terminated
1
13
US
EZM0414
Epizyme, Inc.
Multiple Myeloma, Refractory, Diffuse Large B-Cell Lymphoma, Diffuse Large B Cell Lymphoma Refractory, Multiple Myeloma in Relapse
04/24
04/24
realMIND, NCT04981795: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Recruiting
N/A
100
US
Tafasitamab
Incyte Corporation, Iqvia Pty Ltd
Diffuse Large B-cell Lymphoma
10/25
08/26
Delong, Liu
realMIND, NCT04981795: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Recruiting
N/A
100
US
Tafasitamab
Incyte Corporation, Iqvia Pty Ltd
Diffuse Large B-cell Lymphoma
10/25
08/26
Kavanagh, Laurie
NCT06270641: Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Recruiting
N/A
106
US
ExerciseRx intervention, Exercise Intervention, Best Practice, App-Based Intervention, Interview, Questionnaire Administration
University of Washington
Multiple Sclerosis (MS), Fatigue, Physical Inactivity
04/25
09/26
NCT05848323: Prospective Case Series to Refine Standalone Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue

Completed
N/A
21
US
4-week Relaxation Training, 4-week Behavioral Activation, 4-week Cognitive Therapy
University of Washington
Multiple Sclerosis, Fatigue
09/24
09/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ehde, Dawn M
NCT03782246: MBCT and CBT for Chronic Pain in Multiple Sclerosis

Active, not recruiting
N/A
273
US
MBCT, CBT
University of Washington, National Multiple Sclerosis Society
Multiple Sclerosis
08/22
08/22
E-TIPS, NCT04248725: Telehealth Pain Self-Management for Employed Adults

Completed
N/A
202
US
E-TIPS
University of Washington, National Institute on Disability, Independent Living, and Rehabilitation Research
Chronic Pain, Brain Injuries, Traumatic, Multiple Sclerosis, Spinal Cord Injuries, Amputation
09/23
03/24
NCT06270641: Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Recruiting
N/A
106
US
ExerciseRx intervention, Exercise Intervention, Best Practice, App-Based Intervention, Interview, Questionnaire Administration
University of Washington
Multiple Sclerosis (MS), Fatigue, Physical Inactivity
04/25
09/26
Alschuler, Kevin N
Cubii, NCT05826431: for Exercise in People With MS

Completed
N/A
21
US
Cubii elliptical
University of Washington
Multiple Sclerosis, Fatigue, Activity, Motor, Quality of Life
08/23
12/23
NCT05252195: Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS)

Active, not recruiting
N/A
300
US
University of Michigan, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Wayne State University, University of Washington
Multiple Sclerosis
03/27
03/27
Patrick, Alicia
RESPITE, NCT05625360: REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss

Recruiting
3
160
US
eHealth Mindful Movement and Breathing, Life Impacts Reflection, PROMIS Questionnaires
Wake Forest University Health Sciences, National Cancer Institute (NCI)
Postoperative Pain, Acute, Postoperative Depression, Anxiety, Sleep Disturbance, Malignant Female Reproductive System Neoplasm
08/26
08/26
ASPIRE, NCT06866964: A Single-arm, Phase II Clinical Trial of ASPIRin to PrEvent Venous Thromboembolism in Patients with Advanced Germ Cell Tumors Receiving Chemotherapy

Not yet recruiting
2
35
US
Low-dose ASA, aspirin
Wake Forest University Health Sciences, Atrium Health Wake Forest Baptist
Germ Cell Tumor, Testicular Cancer
08/29
01/31
IMPPACT, NCT04727827: Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation

Completed
N/A
110
US
Pharmacogenomic-guided supportive care
Wake Forest University Health Sciences
Hematopoietic Cell Transplantation, Oncology
06/23
06/23
ACCESS, NCT04602611: Impact Of Nurse Navigation Program on Outcomes in Patients With GI Cancers

Completed
N/A
228
US
Oncology Nurse Navigation
Wake Forest University Health Sciences
Gastrointestinal Cancer
08/23
08/23
NCT04659135: ASCO Survey on COVID-19 in Oncology (ASCO) Registry

Active, not recruiting
N/A
7000
US
American Society of Clinical Oncology
Neoplasms, Coronavirus
08/24
01/25
NCT06291324: WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment

Recruiting
N/A
46
US
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Pancreatic Cancer, Breast Cancer
12/25
12/25
CISTO, NCT03933826: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer

Active, not recruiting
N/A
572
US
University of Washington, Patient-Centered Outcomes Research Institute
Bladder Cancer, Cancer of the Bladder, Recurrent, Non-muscle Invasive Bladder Cancer
01/25
06/29
NCT05415358: Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

Recruiting
N/A
23
US
Blood and tissue samples
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute, Atrium Health Wake Forest Baptist
Lung Cancer, Nonsmall Cell
09/35
09/35
NCT06795087: Discharge Medication Use Post-Operatively in GU Cancer Patients

Recruiting
N/A
684
US
Opioid Medication Disposal Education
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Genitourinary Cancer
07/26
07/26
VAP, NCT06634381: Patient Descriptors of Cancer-Related Fatigue: a Mixed Methods Pilot Study of Cancer Survivors

Recruiting
N/A
80
US
CRF Visual Aid
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Cancer, Fatigue
06/25
06/25
ONC-LUN-2401, NCT06567704: Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

Recruiting
N/A
40
US
Interviews
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Non-small Cell Lung Cancer
04/25
08/25
NCT06489041: Evaluating Microarray Pharmacogenetic Testing in Cancer Patients

Recruiting
N/A
120
US
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Cancer, Gastrointestinal Cancer
05/25
05/25
NCT05934851: A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia

Recruiting
N/A
112
US
Frozen-Section Directed Excision, FSDE, Wide Local Excision
Wake Forest University Health Sciences, Atrium Health Levine Cancer Institute
Vulvar Neoplasm, Dysplasia Vulvar
08/26
03/27
realMIND, NCT04981795: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Recruiting
N/A
100
US
Tafasitamab
Incyte Corporation, Iqvia Pty Ltd
Diffuse Large B-cell Lymphoma
10/25
08/26
PROSPECT, NCT04930445: Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

Terminated
N/A
262
US
Oxbryta® (voxelotor) 500mg Tablets, Voxelotor, Oxbryta®
Pfizer, Pfizer
Sickle Cell Disease
10/24
10/24
Chihara, Dai
NCT06563505: A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

Recruiting
2
36
US
Mosunetuzumab, RO7030816, Zanubrutinib
M.D. Anderson Cancer Center
Lymphoma
12/26
12/28
NCT06670105: A Phase 2 Trial of Glofitamab for Minimal Residual Disease in Patients With Large B-cell Lymphoma

Not yet recruiting
2
30
US
Glofitamab
M.D. Anderson Cancer Center, Genentech, Inc.
B-cell Lymphoma
01/30
01/32
NCT06108232: Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

Recruiting
2
36
US
Obinutuzumab, GA101, Gazyva, RO5072759, CC-99282
M.D. Anderson Cancer Center, Bristol-Myers Squibb
Follicular Lymphoma, Tumor
12/25
12/27
NCT05886036: Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Recruiting
2
70
Canada, US
Biopsy Procedure, Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Mosunetuzumab, Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody BTCT4465A, BTCT 4465A, BTCT-4465A, BTCT4465A, CD20/CD3 BiMAb BTCT4465A, Lunsumio, Mosunetuzumab-axgb, RG 7828, RG-7828, RG7828, RO7030816, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, PT, Rituximab, ABP 798, ABP-798, ABP798, BI 695500, BI-695500, BI695500, Blitzima, C2B8 Monoclonal Antibody, Chimeric Anti-CD20 Antibody, CT P10, CT-P10, CTP10, GP 2013, GP-2013, GP2013, IDEC 102, IDEC-102, IDEC-C2B8, IDEC-C2B8 Monoclonal Antibody, IDEC102, Ikgdar, Mabtas, MabThera, Monoclonal Antibody IDEC-C2B8, PF 05280586, PF-05280586, PF05280586, Riabni, Ritemvia, Rituxan, Rituximab ABBS, Rituximab ARRX, Rituximab Biosimilar ABP 798, Rituximab Biosimilar BI 695500, Rituximab Biosimilar CT-P10, Rituximab Biosimilar GB241, Rituximab Biosimilar GP2013, Rituximab Biosimilar IBI301, Rituximab Biosimilar JHL1101, Rituximab Biosimilar PF-05280586, Rituximab Biosimilar RTXM83, Rituximab Biosimilar SAIT101, Rituximab Biosimilar SIBP-02, rituximab biosimilar TQB2303, Rituximab PVVR, Rituximab-abbs, Rituximab-arrx, Rituximab-blit, Rituximab-pvvr, Rituximab-rite, Rituximab-rixa, Rituximab-rixi, Rixathon, Riximyo, RTXM 83, RTXM-83, RTXM83, Ruxience, Truxima, Rituximab and Hyaluronidase Human, Rituxan Hycela, Rituximab Plus Hyaluronidase, Rituximab/Hyaluronidase, Rituximab/Hyaluronidase Human
National Cancer Institute (NCI)
Nodular Lymphocyte Predominant B-Cell Lymphoma, Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma, Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
10/26
10/26
PROSPECT, NCT04947319: Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma ( Study)

Recruiting
2
112
US
Tirabrutinib, ONO-4059
Ono Pharmaceutical Co. Ltd
Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma
03/27
03/27
NCT06045247: Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Recruiting
2
40
US
Prednisone, Rituximab, Cyclophosphamide, Vincristine, Epcoritamab
M.D. Anderson Cancer Center
Large B-cell Lymphoma
07/28
07/30
SET-101, NCT05121103: A Study of the Safety, Tolerability and Effectiveness of EZM0414 Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma

Terminated
1
13
US
EZM0414
Epizyme, Inc.
Multiple Myeloma, Refractory, Diffuse Large B-Cell Lymphoma, Diffuse Large B Cell Lymphoma Refractory, Multiple Myeloma in Relapse
04/24
04/24
realMIND, NCT04981795: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Recruiting
N/A
100
US
Tafasitamab
Incyte Corporation, Iqvia Pty Ltd
Diffuse Large B-cell Lymphoma
10/25
08/26
Delong, Liu
realMIND, NCT04981795: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Recruiting
N/A
100
US
Tafasitamab
Incyte Corporation, Iqvia Pty Ltd
Diffuse Large B-cell Lymphoma
10/25
08/26
Kavanagh, Laurie
NCT06270641: Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Recruiting
N/A
106
US
ExerciseRx intervention, Exercise Intervention, Best Practice, App-Based Intervention, Interview, Questionnaire Administration
University of Washington
Multiple Sclerosis (MS), Fatigue, Physical Inactivity
04/25
09/26
NCT05848323: Prospective Case Series to Refine Standalone Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue

Completed
N/A
21
US
4-week Relaxation Training, 4-week Behavioral Activation, 4-week Cognitive Therapy
University of Washington
Multiple Sclerosis, Fatigue
09/24
09/24

Download Options